Diligence memo · auto-generated · as of July 2, 2026
DrugStoc
DrugStoc has raised $4.4M over 1 round; too few niche peers to rank its valuation yet.
Businessfiled
DrugStoc is a private company, based in Nigeria, Africa. Nigerian e-health startup DrugStoc has raised US$4.4 million in Series A funding to expand access to quality medicines while providing sustainable supply chain financing for healthcare providers in Sub-Saharan Africa.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
DrugStoc has raised $4.4M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $4.4M on 2021-11-16.
Most recent recorded round closed around 2021-11-16.
Valuation (modeled)modeled
Provath models DrugStoc at approximately $44M (range $6.0M–$174M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Not enough dated financing history to read a financing rhythm.
Comparablesmixed
Capital scale ranks ahead of 99% of sector peers (8525 compared).
Modeled value ranks above 99% of those peers.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.